Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) study

AIMS: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) (NCT02072434) study was a multicentre prospective, randomized, open-label, blinded-endpoint evaluation (PROBE) trial comparing edoxaban with enoxaparin/warfarin followed by warfarin alone in 2199...

Descripción completa

Detalles Bibliográficos
Autores principales: Goette, Andreas, Kwong, Winghan J, Ezekowitz, Michael D, Banach, Maciej, Hjortshoj, Soren P, Zamoryakhin, Dmitry, Lip, Gregory Y H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275467/
https://www.ncbi.nlm.nih.gov/pubmed/29947751
http://dx.doi.org/10.1093/europace/euy141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275467/
https://www.ncbi.nlm.nih.gov/pubmed/29947751
http://dx.doi.org/10.1093/europace/euy141

Ejemplares similares